| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | FAB193A | |||
| Carrier Free | FAB193F | |||
| Carrier Free | FAB193P | |||
| Carrier Free | AF193-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-97637SS | |||
| BSA Free | NBP1-97637-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF593-SP | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 350 | FAB5931U-100UG | |||
| Alexa Fluor 405 | FAB5931V-100UG | |||
| Alexa Fluor 488 | FAB5931G-100UG | |||
| Alexa Fluor 532 | FAB5931X-100UG | |||
| Alexa Fluor 594 | FAB5931T-100UG | |||
| Alexa Fluor 647 | FAB5931R-100UG | |||
| Alexa Fluor 700 | FAB5931N-100UG | |||
| Alexa Fluor 750 | FAB5931S-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB5931-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB193-SP | |||
| Carrier Free | MAB193-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34903-1mg | |||
| Carrier-Free | NBP2-34903-100ug | |||
| Carrier-Free | NBP2-34903-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76774-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB593-SP | |||
![Immunohistochemistry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Immunostaining of HEK 293 cells transfected with a human BCMA expression plasmid (left panel), or mock transfected (right panel). Method: 3 days after transfection of cells with the indicated constructs, cells were fixed with acetone or 4% formaldehyde for 5 min. at room temperature. Slides were blocked with normal IgG, and incubated for 1 hour with 5ug/ml MAb to BCMA (human) (Vicky-1) in 1% BSA in 1x PBS. After washes in PBS, samples were incubated with the secondary antibody for 1 hour, washed in PBS and revealed with StreptABComplex/HRP (Vector) and AEC.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Immunohistochemistry-NBP1-97637-img0007.jpg "Immunohistochemistry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Immunostaining of HEK 293 cells transfected with a human BCMA expression plasmid (left panel), or mock transfected (right panel). Method: 3 days after transfection of cells with the indicated constructs, cells were fixed with acetone or 4% formaldehyde for 5 min. at room temperature. Slides were blocked with normal IgG, and incubated for 1 hour with 5ug/ml MAb to BCMA (human) (Vicky-1) in 1% BSA in 1x PBS. After washes in PBS, samples were incubated with the secondary antibody for 1 hour, washed in PBS and revealed with StreptABComplex/HRP (Vector) and AEC.")
![Flow Cytometry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Analysis using the PE conjugate of NBP1-97637. Staining of 10^6 U266 cells using BCMA (human), mAb (Vicky-1) (PE conjugate) at a concentration of 10ug/ml.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Flow-Cytometry-NBP1-97637-img0011.jpg)
![Flow Cytometry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Detection of endogenous human BCMA with MAb to BCMA (human) (Vicky-1). Method: U266 cells (2x10^5) were incubated on ice for 30 min. with 0.2ug of MAb to BCMA (human) (Vicky-1) or an isotype control in 25ul FACS buffer (PBS, 5% fetal calf serum, 0.02% azide). The primary antibody was revealed with PAb to Rat IgG (R-PE) and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Flow-Cytometry-NBP1-97637-img0006.jpg)
![Flow Cytometry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Analysis using the FITC conjugate of NBP1-97637. Staining of 10^6 Jurkat cells using BCMA (human), mAb (Vicky-1) (FITC conjugate) at a concentration of 50ug/ml.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Flow-Cytometry-NBP1-97637-img0010.jpg)
![N/A BCMA/TNFRSF17 [Biotin]](http://images.novusbio.com/fullsize2/DATA_BCMA_DY193_ELISA_1736.jpg "N/A BCMA/TNFRSF17 [Biotin]")
![N/A BCMA/TNFRSF17 [Biotin]](http://images.novusbio.com/fullsize2/DATA_BCMA_DY593_ELISA_2142.jpg "N/A BCMA/TNFRSF17 [Biotin]")
![Western Blot: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen (A) tissue lysate, K562 (B), and U937 (C) cell lysates with BCMA antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Western-Blot-NBP1-76774-img0002.jpg "Western Blot: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen (A) tissue lysate, K562 (B), and U937 (C) cell lysates with BCMA antibody at 5 ug/ml.")
![Immunohistochemistry-Paraffin: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen tissue with BCMA antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Immunohistochemistry-Paraffin-NBP1-76774-img0005.jpg)
![Immunocytochemistry/ Immunofluorescence: BCMA/TNFRSF17 Antibody - BSA Free [NBP1-76774] - Immunofluorescence of BCMA/TNFRSF17 in Human Spleen tissue with BCMA/TNFRSF17 antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp1-76774_rabbit-polyclonal-bcma-tnfrsf17-antibody-2711202420285861.jpg)
![Immunohistochemistry: BCMA/TNFRSF17 Antibody - BSA Free [NBP1-76774] - Immunohistochemistry of BCMA/TNFRSF17 in human spleen tissue with BCMA/TNFRSF17 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76774_rabbit-polyclonal-bcma-tnfrsf17-antibody-2711202420414573.gif)